SHELLEY BROWN: Open Payments
NPI 1467624205 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 35 payments from 13 companies in 2025. Trend: 2023 $535 · 2024 $718 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $164 |
| PFIZER INC. | 4 | $87 |
| Novo Nordisk Inc | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Amgen Inc. | 3 | $48 |
| Astellas Pharma US Inc | 2 | $44 |
| Exact Sciences Corporation | 2 | $32 |
| Abbott Laboratories | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $16 |
Products named: UBRELVY, QULIPTA, OTEZLA, Wegovy, Veozah, NURTEC ODT, AIRSUPRA, Cologuard Collection Kit.
Industry payments across NC — which companies pay providers there.
